| __timestamp | Agios Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19120000 | 504755000 |
| Thursday, January 1, 2015 | 35992000 | 838526000 |
| Friday, January 1, 2016 | 50714000 | 1177697000 |
| Sunday, January 1, 2017 | 71124000 | 1320433000 |
| Monday, January 1, 2018 | 114145000 | 1556200000 |
| Tuesday, January 1, 2019 | 132034000 | 1834800000 |
| Wednesday, January 1, 2020 | 149070000 | 1346000000 |
| Friday, January 1, 2021 | 121445000 | 1824900000 |
| Saturday, January 1, 2022 | 121673000 | 2115900000 |
| Sunday, January 1, 2023 | 119903000 | 2631300000 |
| Monday, January 1, 2024 | 156784000 | 2954400000 |
Cracking the code
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Regeneron Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. have showcased contrasting strategies in this domain. From 2014 to 2023, Regeneron's SG&A expenses surged by over 400%, peaking at approximately $2.63 billion in 2023. This reflects their aggressive expansion and market penetration strategies. In contrast, Agios Pharmaceuticals maintained a more conservative growth, with SG&A expenses increasing by around 500% to $120 million in the same period. This disparity highlights Regeneron's robust market presence compared to Agios's focused approach. As the biotech landscape evolves, these trends offer valuable insights into how companies balance growth with operational efficiency.
Johnson & Johnson vs Agios Pharmaceuticals, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: AstraZeneca PLC vs Regeneron Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Summit Therapeutics Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Intra-Cellular Therapies, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs ImmunityBio, Inc.
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Agios Pharmaceuticals, Inc.
Summit Therapeutics Inc. vs Agios Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Agios Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Cytokinetics, Incorporated and Agios Pharmaceuticals, Inc.
Opthea Limited and Agios Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Protagonist Therapeutics, Inc. or Agios Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?